Traverso Chambers Private Wealth Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $166K | Hold |
|
|||||
|
2023
Q2 | $240K | Hold |
|
|||||
|
2023
Q1 | $241K | Hold |
|
|||||
|
2022
Q4 | $150K | Hold |
|
|||||
|
2022
Q3 | $198K | Hold |
|
|||||
|
2022
Q2 | $188K | Hold |
|
|||||
|
2022
Q1 | $261K | Hold |
|
|||||
|
2021
Q4 | $286K | Hold |
|
|||||
|
2021
Q3 | $334K | Hold |
|
|||||
|
2021
Q2 | $317K | Hold |
|
|||||
|
2021
Q1 | $315K | Sell |
|
|||||
|
2020
Q4 | $333K | Hold |
|
|||||
|
2020
Q3 | $220K | Hold |
|
|||||
|
2020
Q2 | $191K | Hold |
|
|||||
|
2020
Q1 | $241K | Buy |
|
|||||
|
2019
Q4 | $323K | Buy |
|